汇添富中证医药ETF联接C(007077)利润分配表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 收入 |
-17,442,390.81 |
18,316,086.09 |
8,166,431.42 |
-34,110,513.06 |
| 利息合计 |
24,525.38 |
51,458.63 |
25,061.23 |
51,379.49 |
| 其中:存款利息收入 |
24,525.38 |
51,458.63 |
25,061.23 |
51,379.49 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-1,455,220.92 |
-16,956,191.87 |
-8,658,474.86 |
-15,393,382.83 |
| 其中:股票投资收益 |
-124,642.19 |
103.38 |
24,208.04 |
-75,257.38 |
| 基金投资收益 |
-1,330,578.73 |
-16,952,389.44 |
-8,678,777.09 |
-15,338,578.40 |
| 债券投资收益 |
- |
-3,905.81 |
-3,905.81 |
17,177.85 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
- |
- |
- |
3,275.10 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-16,045,314.64 |
35,144,304.94 |
16,766,473.86 |
-18,999,929.12 |
| 其他收入 |
33,619.37 |
76,514.39 |
33,371.19 |
231,419.40 |
| 费用 |
314,684.27 |
723,563.19 |
381,510.38 |
790,824.16 |
| 管理人报酬 |
32,371.97 |
68,327.25 |
35,048.43 |
69,895.27 |
| 基金托管费 |
6,474.37 |
13,665.37 |
7,009.64 |
13,979.04 |
| 销售服务费 |
193,883.07 |
476,336.57 |
257,497.45 |
541,715.85 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
81,954.86 |
165,234.00 |
81,954.86 |
165,234.00 |
| 利润总额 |
-17,757,075.08 |
17,592,522.90 |
7,784,921.04 |
-34,901,337.22 |